Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Agios, Bayesian, Coya, Eli Lilly, Roche.

Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Apyx, Argenx, Biozen, Corvention, Fujirebio, H.U. Group Holdings, Innovent, Partner, Shionogi, Sironax, Transpire, Viiv, Zai Lab, Zhejiang Wenda.

Regulatory snapshots for biopharma and med tech in Asia-Pacific, including global submissions and approvals, and other regulatory decisions and designations: Bioarctic, Chance, Eisai, Kelun-Biotech, Lanexa, Mezzion, Norgine, Rznomics, Specialised, Sunshine Lake, Ultragreen.ai.

Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Bioarctic, BMS, Chance, Eisai, Kelun-Biotech, Mezzion, Rivanna, Rznomics.

Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Armata, Atara, Bright Uro, Microsure, Partner, Repertoire.

Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Artera, Bridgebio, Diakonos, Norgine, Nuvation.

Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Clear Scientific, Fate, Multi4, Neurocare, Opus Genetics, Ultragreen.ai.

Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied Biocode, Arvinas, Atossa, Clene, E-scopics, Incyte, Lanexa, Pfizer, Satellite, Specialised, Sunshine, Zeta.

Regulatory snapshots for biopharma and med tech in Asia-Pacific, including global submissions and approvals, and other regulatory decisions and designations: Arrowhead, Claruvis, Curocell, Dr. Reddy’s, Emergent, Henlius, Hutchmed, Kyowa Kirin, Orchard, Telix.

Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Arrowhead, Astrazeneca, Axsome, MRM, Orchestra, Rhythm, Royal Philips, Taewoong, Telix.